SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : I Will Continue to Continue, to Pretend.... -- Ignore unavailable to you. Want to Upgrade?


To: Sully- who wrote (21600)7/19/2006 7:14:37 PM
From: Sully-  Respond to of 35834
 
Today's Funnies:

TownHall.com



townhall.com



To: Sully- who wrote (21600)7/19/2006 9:19:53 PM
From: Sully-  Respond to of 35834
 
    [W]e are encoded at conception as human, and human we 
remain from the moment of conception until our death. Our
DNA and genetic composition is a fact, not a belief, and
cell division demonstrates life, as any biologist will
tell you. Facts. Not beliefs.

Bush Casts First Veto On Embryonic Stem-Cell Funding

By Captain Ed on National Politics
Captain's Quarters

George Bush waited 2,006 days to cast the first veto of his presidency, and it comes on an issue for which he has threatened a veto for at least 2,006 days. As Congress considered a bill authorizing federal funding for embryonic stem-cell research, Bush warned that he would not allow it to become law, and he made good on that promise this afternoon:

<<< President Bush today used the first veto of his presidency to stop legislation that would have lifted restrictions on federally funded human embryonic stem cell research.

"This bill would support the taking of innocent human life in the hope of finding medical benefits for others," Bush, speaking at the White House, said after he followed through on his promise to veto the bill. "It crosses a moral boundary that our decent society needs to respect. So I vetoed it." ...

The Senate voted 63 to 37 yesterday to approve the bill, passed by the House last year, that would expand spending for research on stem cell lines derived from frozen embryos that are stored at fertility clinics and slated for destruction.

Such research is controversial because it holds the promise of finding cures for major diseases, such as Parkinson's, but requires destroying human embryos to extract the cells.

Bush addressed the issue in the White House's East Room surrounded by two dozen families -- including one from Alexandria, another from Ellicott City -- who adopted frozen embryos not wanted by other couples and used the embryos to have children. >>>


This crossed one of the bright lines of Bush's stated policy. However one wants to define this issue, destroying human embryos to fashion treatments amounts to trading one life for another. As Bush said in his veto, these are not spare parts but human life. These embryos contain human DNA and they have grown into multicelluar states, showing life, and life that is undeniably human. I wrote this two years ago:


<<< I believe that life begins within minutes of conception, and that belief is based on science, not faith, although they intersect. Eggs and sperm carry 23 chromosomes, half of the genetic blueprint for human life. Even if other primates have the same chromosome count, the DNA encoding on human eggs and sperm is uniquely human. When the sperm fertilizes the egg, the separate DNA strands combine into 23 pairs of chromosomes and a unique blueprint for a unique human being. Once the cell divides on its own -- usually within a half-hour -- that being is alive, unique, and separate from, though dependent on, its mother.

Some have argued this point for decades. Phil Donahue, years ago, once said on television that a human being in the womb passes through stages where it becomes a fish, then a dog, and so on; this argument arises amongst the ignorant often. Science teaches us that this is folk-tale nonsense. Vertebrates in the womb all pass through similar stages of development, but we are encoded at conception as human, and human we remain from the moment of conception until our death. Our DNA and genetic composition is a fact, not a belief, and cell division demonstrates life, as any biologist will tell you. Facts. Not beliefs.

What to do with this life then becomes a question more of values than of faith. Do we sacrifice innocent human life for the sake of convenience or economics? Throughout the history of Western civilization, we have answered that with a resounding NO. We enact laws, construct family structures, and develop moral and social structures in order to protect and to nurture it. When we have devalued innocent life, Holocausts have resulted, such as the Nazi atrocities (even apart from the Final Solution) of forced abortions and euthanasia of the so-called undesirable elements, such as the sickly, the less intelligent, the handicapped, and the simply different. >>>

Congress wanted to treat human life as a commodity instead of protecting it in all its forms. Bush made the right call in vetoing federal funding for these programs.

Undoubtedly, we will hear plenty from critics that Bush has endangered the health of Americans through his veto, a conclusion bordering on the absurd. Putting aside the fact that we shouldn't grind up humans to save other humans, this veto doesn't ban any kind of research at all. It just makes human embryonic stem-cell (hESC) research ineligible for federal funding. It's not a ban, and in fact that research has never been banned within the US.

The lack of federal funding should make little difference, if the science is sound for hESC. It's not, or at least it isn't commercially viable, which is why researchers want the federal government to pay for it. Pharmaceuticals won't underwrite it because adult stem cells and umbilical-cord stem cells have had much more success. They have produced actual medical treatments, where hESCs have had little real success. California planned on spending $2 billion on ESC, and we have yet to hear of any breakthroughs from that research.
(I wrote about this in September 2004 for the New York Sun - see link below.) The lack of private investment in this procedure tells volumes about its value.

Congress may try an override on this veto, but I doubt it will find the necessary votes. The bill only got 63 votes in the Senate on passage, four short of an override. Congress finally found Bush's limits after five and half years in office, and he's not budging.

UPDATE: Congress failed to override the veto, only garnering 235 votes -- 51 fewer than needed.

captainsquartersblog.com

washingtonpost.com

captainsquartersblog.com

captainsquartersblog.com

news.yahoo.com



To: Sully- who wrote (21600)7/20/2006 8:57:27 PM
From: Sully-  Respond to of 35834
 
Science’s Stem Cell Scam

By Michael Fumento
TownHall.com
Thursday, July 20, 2006

Embryonic stem cells (ESCs) receive tremendous media attention, with oft-repeated claims that they have the potential to cure virtually every disease known. Yet there are spoilsports, self included, who point out that they have yet to even make it into a human clinical trial. This is even as alternatives – adult stem cells (ASCs) from numerous places in the body as well as umbilical cord blood and placenta – are curing diseases here and now and have been doing so for decades. And that makes ESC advocates very, very angry.

How many diseases ASCs can treat or cure is debatable, with one website claiming almost 80 for umbilical cord blood alone. Dr. David Prentice of the Family Research Council, using stricter standards of evidence, has constituted a list of 72 for all types of ASCs. But now three ESC advocates have directly challenged Prentice’s list. They’ve published a letter in Science magazine, released ahead of publication obviously to influence Pres. Bush’s promise to veto legislation that would open wide the federal funding spigot for ESC research. The letter claims ASC “treatments fully tested in all required phases of clinical trials and approved by the U.S Food and Drug Administration are available to treat only nine of the conditions” on his list.

Well! One answer to that is that it’s nine more than can be claimed for ESCs. Further, there are 1175 clinical trials for ASCs, including those no longer recruiting patients, with zero for ESCs. But a better response is that the letter authors come from the Kenneth Lay School for honesty, as do the editors at Science.

In the detailed attachment to their letter, the Science magazine writers aren’t just at odds with Prentice but the medical community as a whole. For example, regarding sickle cell anemia, they claim “adult stem cell transplants from bone marrow or umbilical cord blood can provide some benefit to sickle cell patients” and “hold the potential to treat sickle cell anemia.” “Some benefit” and “potential?”

An article from the May 2006 issue of Current Opinion in Hematology notes that “there is presently no curative therapy” for sickle cell anemia other than allogeneic hematopoietic stem cell transplantation. “Hematopoietic” means from marrow or blood; “allogeneic” means the cells are from another person. Seminars in Hematology (2004) states, “. . . curative allogeneic stem cell transplantation therapy” has “been developed for sickle cell anemia.” Meanwhile, “. . . curative allogeneic stem cell transplantation therapy [has] been developed for” sickle cell anemia according to Current Opinions in Molecular Therapy (2003), while “hematopoietic stem cells for allogeneic transplantation” are “currently the only curative approach for sickle cell anemia” observes the journal Blood (2002). (All emphasis mine.)

What does everybody seem to know that the Science writers and Science editors don’t?

Words like “could” and “potential” are trick phraseology used throughout the letter attachment for ASC curative therapies that have been used routinely for years. This appears to give them no advantage over ESC therapy, all of which boasts nothing but potential.

The writers are correct about FDA approval; but that’s a trick. Some ASC therapies are approved in other countries but not yet here. More importantly, stem cell therapy is not a drug and therefore the FDA doesn’t regulate it the same way. Some have been used successfully for decades with no one seeking or receiving federal approval.

For that matter, aspirin is a drug but by their standards it only has potential use for aches and pains since it never went through the clinical trial process and the FDA has never given it formal approval.

How can Science not know all this? Simple; it does. I’ve written repeatedly of how Science has made itself a propaganda sheet for ESC research, as well as other political causes. At the least, it should change its name to Pseudoscience. Sometimes it prints easily falsifiable studies, such as this, attacking the usefulness of ASCs. Other times it falsely promotes ESCs. That culminated in January when the journal was forced to retract two groundbreaking ESC studies that proved frauds.

The journal wants to flood unpromising ESC research with taxpayer dollars because private investors know just how very unpromising it is. Now yet again Science has showcased the scientific and moral bankruptcy of the entire ESC advocacy movement.

townhall.com



To: Sully- who wrote (21600)7/21/2006 12:52:26 AM
From: Sully-  Respond to of 35834
 
Europe and Embryonic-Stem-Cell Research

Kathryn Jean Lopez
The Corner

On the road to being more protective of the embryo than us, too? From Reuters :


<<< BRUSSELS (Reuters) - Germany pressed its EU partners to ban European funding for embryonic stem-cell research, a day after President George W. Bush vetoed a bill that would have expanded such work in the United States.

The European Union science programme should not be used to give financial incentives to kill embryos," German Research Minister Annette Schavan wrote in a letter seen by Reuters on Thursday before a meeting on EU science funding on Monday.

"The current proposal from the European Commission and the European Parliament does not rule this out." >>>

corner.nationalreview.com

news.yahoo.com



To: Sully- who wrote (21600)8/24/2006 4:31:19 PM
From: Sully-  Respond to of 35834
 
Should New Stem Cell Procedure Unlock Federal Funding?

By Captain Ed on Science
Captain's Quarters

The announcement of a new, non-destructive method of deriving stem cells from embryos raised hopes that the Bush administration would lift restrictions on federal funding for human embryonic stem-cell (hEsc) research. The new process takes one or two cells from a blastocyst in a similar method as in-vitro fertilization checks for genetic abnormalities and then grows the cells into theoretically perpetual stem-cell lines. This eliminates the need for the destruction of the embryo and arguable removes the moral objection to funding the process:

<<< Now a team at Advanced Cell Technology - a private company - has found that it is possible to create human stem cells using one or two cells from an early embryo, without doing any damage to the embryo.

In theory, the technique could be used to create both a baby and a set of immortal stem cells unique to that baby that might be used decades later to cure the baby - now adult - of diseases such as Parkinson’s or heart disease.

Much more likely, however, is that it will be used as a research technique to advance stem-cell science.

The technique is similar to pre-implantation genetic diagnosis (PGD) where one or two cells are detached from a blastocyst - a very early embryo, created in the case by in-vitro fertilisation - and tested to see if it carries a genetic mutation. >>>

Undoubtedly, this puts a much different light on hEsc research. In fact, it might force hEsc researchers to adopt this method regardless of the existence of federal funding, as any destruction of embryos will be demonstratedly unnecessary. In that sense, the new technique removes a cloud that has hovered over this science since its inception.

Will it be enough to allow for federal funding of hEsc? Politically speaking, I'd say yes. The primary objection to funding hEsc has been the destruction of human embryos. If that stops, then most of the current objections vanish. Certainly the science has other deep ethical issues, including the questions of cloning humans for medical purposes and ownership of the cells and cell lines. None of these, however, have been cited as a reason to block hEsc funding, and the same dilemmas exist for adult and placental stem-cell research anyway.

There are other problems with hEsc research and federal funding. The hEsc efforts have come up empty for the most part; the adult and placental pursuits have resulted in actual therapies and better-controlled processes. One of the reasons why hEsc researchers pressed for federal funding (and repeatedly mischaracterized the lack of such as a "ban" on research) is precisely because the science has shown no practical reward to this point. Private funding has gone towards the sciences that have delivered more tangible victories, resulting in a market decision that marginalizes hEsc.

The question of federal funding for hEsc is one that applies to most federal funding, and that is market distortion. Will federal dollars skew the research market to the point where scientists spend disproportionate resources on less-promising processes, further delaying medical advances rather than promoting them? Market forces can produce short-sighted perspectives, but I'd trust the market over the decisions of a handful of bureaucrats and political appointees about the potential of various directions in medical research.

However, I expect that these questions will not hold back the advocates of hEsc and the claims of miracle cures that privately-funded hEsc research has failed to produce. With the main ethical argument neutered (and with full recognition of the blessings of the new procedure), Congress and the Bush administration will probably rush to provide funds for hEsc research along these lines.

UPDATE: Hugh Hewitt is right about this being a victory for anti-hEsc forces. Without the economic pressure to find a non-destructive method to develop embryonic stem cells, how much longer would we have waited for this breakthrough? Would it have ever come?

captainsquartersblog.com

timesonline.co.uk

hughhewitt.townhall.com



To: Sully- who wrote (21600)8/28/2006 3:57:50 PM
From: Sully-  Read Replies (5) | Respond to of 35834
 
Science by Press Release

More hype from stem cell entrepreneurs.

by Wesley J. Smith
The Weekly Standard
09/04/2006

"NEW STEM CELL METHOD avoids destroying em-bryos," the New York Times headline blared. "Stem cell breakthrough may end political logjam," chimed in the Los Angeles Times. "Embryos spared in stem cell creation," affirmed USA Today. Reporting the same supposed scientific achievement by Advanced Cell Technology (ACT), the Washington Post quoted the company's bioethics adviser Ronald Green: "You can honestly say this cell line is from an embryo that was in no way harmed or destroyed."

Unfortunately, you can't "honestly" say that.
The above headlines--like Green's statement and innumerable similar press accounts around the world--are just plain wrong. While ACT did indeed issue a press release heralding its embryonic stem cell experiment as having "successfully generated human embryonic stem cells using an approach that does not harm embryos," the actual report of the research led by ACT chief scientist Robert Lanza, published in Nature, tells a very different story. In fact, Lanza destroyed all 16 of the embryos he used, just as in conventional embryonic stem cell research.

And that's not the only facet of Lanza's work that the press got wrong. The ACT team did do something new: It worked with very early embryos, of 8 to 10 cells each, rather than the 100- to 200-cell blastocysts usually used in such research. From each of these early embryos, the scientists removed not one cell--as several press accounts reported--but 4 to 7 cells. This misreporting is important because it creates a materially false impression.

During in vitro fertilization of an egg, a single cell
can be removed from a very early embryo like those Lanza used in his research. Usually this is done for genetic testing, before the embryo is implanted in the mother, and the embryo remains viable--unlike Lanza's embryos. Lanza did, however, derive two lines of embryonic stem cells from some of the early cells he had removed. Maybe one day someone will succeed in making stem cell lines from an early embryo that survives, but Lanza didn't. ACT and the media--in their desire to boost popular support for embryonic stem cell research--simply took a leap of faith and portrayed an experiment showing that something might be possible as if the feat had already been accomplished.

Reporters should be more sophisticated. They should know that the history of science is rife with promising early experiments that never came to fruition. Reporters should be especially aware of this in the field of cloning research, where the old saying, "Fool me once, shame on you, fool me twice, shame on me," definitely applies.

And this is especially relevant to ACT. For, though the company has never been guilty of the outright scientific fraud perpetrated by South Korean cloning re searcher Wu-suk Hwang, its misleading press release is all too typical. In the last few years, ACT's publicity department has repeatedly generated high-visibility stories about supposed scientific breakthroughs--which turned out later to be grossly exaggerated or flat-out false.

In the December 3, 2001, issue of U.S. News and World Report, for example, a nine-page cover story by Jo annie Fischer extolled the creation by ACT scientists of the first cloned human embryos. But ACT's supposed coup shriveled on inspection. A human egg can be made to divide a few times without actually turning into a viable embryo. The ACT report was quickly debunked by the science community. Rudolf Jaenisch, a cloning expert at the Massachusetts Institute of Technology, scathingly dismissed it as "third-rate science."

Undeterred by ACT's hyping of its efforts, the Atlantic Monthly ran a story by Kyla Dunn less than seven months later. Titled "Cloning Trevor," it amounted to 16 pages of boosterism for the company's cloning research--even as it acknowledged in passing that the development previously reported by U.S. News was "largely judged to be preliminary, inconsequential, and certainly not worthy of headlines."

"Cloning Trevor" described ACT's attempt to create a cloned embryo of a young boy named Trevor, described as suffering from "a rare and devastating genetic disease." The malady is treatable with bone marrow or umbilical cord blood transplants. But in a few cases, the patient's immune system rejects the transplanted cells, threatening his life. Rather than risk those side effects, Trevor's parents traveled to ACT to have him treated with cloned embryonic stem cells.

For several pages, the article lauded the scientists at ACT, only to reveal that "all hopes for developing an experimental cure for Trevor were dashed" when the boy developed early symptoms of his disease, and his parents were forced to turn to traditional treatments. In reality, of course, there was never any hope of treating Trevor with cloned embryonic stem cells. Even if a cloned embryo had been created from Trevor's DNA, and stem cells had been derived from this cloned embryo--a feat still to this day beyond the reach of science--injecting the cells into the boy would have been blatantly unethical because of grave safety concerns. It might even have amounted to illegal human experimentation.

In January 2004, ACT again was the subject of laudatory international headlines when Wired magazine carried a breathless report by Wendy Goldman Rohm to the effect that Lanza had successfully grown cloned human embryos to the 16-cell stage. This would have been big news--if it had been verified. But it never was. To my knowledge, Lanza never subjected his work to peer review or published a report of it in a respected science journal. Moreover, ACT president Michael West refused to confirm to the Economist that the company had created a 16-cell cloned human embryo.

So now, it's déjà vu all over again, with ACT lionized by a media stampede over a purported research breakthrough that the company did not actually achieve.
This is not to say, of course, that deriving embryonic stem cell lines from a procedure that allows the embryo to survive is impossible--only that it hasn't been done. Lanza's experiment does demonstrate that stem cell lines can be obtained earlier than previously thought. But that wasn't good enough for ACT's pub licity office or the lazy reporters who regurgitated the press release. The failure to report this story accurately amounts to massive journalistic malpractice--and once again ACT is laughing all the way to the bank.

Wesley J. Smith is a senior fellow at the Discovery Institute and a special consultant to the Center for Bioethics and Culture. His current book is Consumer's Guide to a Brave New World.

weeklystandard.com



To: Sully- who wrote (21600)2/8/2007 4:47:40 PM
From: Sully-  Respond to of 35834
 
Code of Silence

Another source of useful stem cells has been found--and the media and the cloning crowd are trying keep it quiet.

by Michael Fumento
The Weekly Standard
02/08/2007

WHILE THE DEMOCRATIC-CONTROLLED House voted 253-174 to expand federal funding for embryonic stem-cell research, it fell far short of the 290 votes needed to override a virtually guaranteed presidential veto. A tragedy for victims of everything from Alzheimer's to warts? Not at all. Each year there are stunning breakthroughs with adult stem cells, and 2007 has already brought its first.

Adult stem cells cure and treat more 70 diseases and are involved in almost 1,300 human clinical trials. Scientists also keep discovering that adult stem cells are capable of creating a wider variety of mature cells. Perhaps the most promising of these was announced in the January issue of Nature Biotechnology.

Anthony Atala, director of the Institute for Regenerative Medicine at Wake Forest University School of Medicine, reported that stem cells in the amniotic fluid that fills the sac surrounding the fetus may be just as versatile as embryonic stem cells. At the same time they maintain all the advantages that have made adult stem cells such a success.

This has caused great consternation on the part of those seeking increased taxpayer embryonic stem cell funds. The reason is that there are currently no practical applications for this type of cell. There hasn't even been a single clinical trial involving them. Researchers admit we won't have approved embryonic stem cell treatments for at least 10 years.

One advantage of embryonic stem cells has been that most types of adult stem cells cannot be multiplied outside of the body for very long, while embryonic ones may replicate in the lab indefinitely. But Atala's new amniotic stem cells grow as fast outside the body as embryonic stem cells (doubling every 36 hours), and he's now been growing the same cell line for two years, with no indication of slowing.

That leaves embryonic stem cells with only one possible advantage--potential. Embryonic stem cells can be "differentiated" into all three "germ layers," or subtypes of cell. That means they should be able to be made into all of the 220 types of cells in humans. For a long while, adult stem cells were believed to be only capable of differentiation to a limited number of mature cells, depending on the type of adult stem cell with which you start. For example, a marrow cell could become any number of types of marrow or blood cells, but it couldn't become a muscle cell. That's a different germ layer.

Yet it's been virtually a state secret that for over five years researchers, beginning with a team headed by physician Catherine Verfaillie of the University of Minnesota Stem Cell Institute, have been reporting numerous types of adult stem cells (she used those from marrow) that in the lab could form mature cells from three germ layers. Experiments around the world have clearly shown that adult stem cells from one germ layer can be converted into those of another in a living human, such as those that turned marrow cells into heart muscle and blood vessels in live humans.

That said, amniotic stem cells may be the most easily differentiated of all--as well as among the easiest to extract in large amounts.
Indeed, they are routinely recovered with a hypodermic needle during amniocentesis. While it's widely believed that this procedure slightly increases the chance of miscarriage, a sizable study last November of 35,000 women who underwent mid-trimester testing found "no significant difference in loss rates between those undergoing amniocentesis and those not undergoing amniocentesis."

THERE ARE OVER four million births each year in the United States, yet Atala calculates that merely 100,000 amniotic stem cell specimens could supply 99 percent of the U.S. population's needs for perfect matches for transplants.
(That assumes a perfect match is even needed.) About 700,000 amniocentesis procedures are performed in the United States and Western Europe each year.

Some embryonic stem cell researchers have downplayed the Atala findings.
The work will "still require a lot of replication from other groups before they can be conclusive," Stephen Minger, an embryonic stem cell scientist identified only as a "lecturer in stem-cell biology" told a British newspaper. "They have only shown that these particular stem cells can turn into a couple of different types of other stem cells. I would say that a hell of a lot more work is required." Other media outlets would say the same. Newsweek International claimed, "Many scientists are quick to emphasize that comprehensive human trials are still many years away."

The New York Times refused even to allow people to read between the lines--they simply never reported the news about Atala's work.
When a reader complained to the "Public Editor," an online ombudsman, about the omission, the Times responded that its genetics reporter, Nicholas Wade, "looked at the Atala paper last week and deemed it a minor development." Wade said of the paper, "It reports finding 'multipotent' stem cells in amniotic fluid. Multipotent means they can't do as much as bona fide embryonic stem cells (which are called 'pluripotent')."

Neither Minger nor Newsweek nor Wade could be more wrong.
As Atala told PBS's Online NewsHour, "We have been able to drive the cell to what we call all three germ layers, which basically means all three major classes of tissues available in the body, from which all cells come from." I pointed out in a response to the New York Times posting that merely reading the online abstract of the Atala paper indicated the same. Of course, this is the same paper that told readers in 2004 that there were no cures or treatments with adult stem cells. Not 70 cures or treatments, some dating back half a century--none.

It is neither paranoia nor exaggeration to say that the New York Times is engaged in a stem-cell cover-up.

WHAT MAKES all of this worse is that Atala's work actually is a replication of numerous studies.
He's just taken the research further and pulled his cells from amniotic fluid, whereas others have pulled the identical cells from the placenta. Amniotic and placenta stem cells are the same, as Atala himself noted. And as to human trials being "many years away," Newsweek is correct only if "years away" means "years ago." The New England Journal of Medicine carried one paper on a placenta stem cell trial back in 1996 and another paper two years later. There's been one ongoing clinical trial since 2001 to treat sickle cell anemia. The Washington Post's Rick Weiss, who has been accused of boosterism for embryonic stem cell research, tried to find a middle ground, saying that "The new [sic] cells are adding credence to an emerging consensus among experts that the popular distinction between embryonic and 'adult' stem cells--those isolated from adult bone marrow and other organs--is artificial."

Actually, what's "artificial" is the term "adult stem cell," which worked fine not so long ago when all adult stem cells were all pulled from bone marrow, but is confusing now that they're being extracted from placentas, amniotic fluid, and umbilical cords, which aren't exactly "adult" sources. But for discussions both scientific and moral, stem cells can still be broken down between the embryonic and the non-embryonic.

Scientifically, all embryonic stem cells tend to become cancerous; they require permanent, dangerous, immunosuppressive drugs because the body rejects them as foreign; and they are difficult to differentiate into the needed type of mature cells. Non-embryonic stem cells, however, do not become cancerous; they are far less likely to cause rejection (especially the youngest, including umbilical cord and amniotic/placenta); and they have been used therapeutically since the late 1950s (originally for leukemia) because they have the amazing ability to form the right type of mature cell merely upon being injected into a body that needs that type of cell.

It is these biological differences that have held embryonic stem cell research back, not a lack of federal funds.

As stem-cell researcher Malcolm Alison of the University of London told the Daily Mail, the amniotic cells "appear to be at least as malleable as embryonic stem cells but without all the ethical baggage."

For all the talk over the morality of using human embryos in medicine, perhaps there's another moral issue at play: Non-embryonic stem cell researchers are already performing miracles, such as growing new heart and liver tissue and treating multiple sclerosis--all in living humans. Yet they struggle to get federal funds for their research. Given the growing number of state initiatives that fund embryonic stem cell, but not non-embryonic stem cell, research and given that overall National Institutes of Health funding increases are unlikely anytime soon, is it truly moral to take away funds from a technology that's been saving lives for half a century in favor of another technology that promises nothing but "promise"?


Michael Fumento is a D.C.-based health, science, and military writer.

weeklystandard.com



To: Sully- who wrote (21600)4/3/2007 12:30:10 AM
From: Sully-  Respond to of 35834
 
This is what happens when Dem's gain power by any means necessary..... The Big Lie run amok.
    The moral of the story is that those who claim to be 
on the side of “science” and “reason” are not necessarily
wedded to either one when it comes to the politics of
embryonic research. Voters in other states should bear
this in mind when this bandwagon comes to their towns.

Nascent Falsehood

If embryonic research is so promising, why do its backers need to lie?

By David Freddoso
National Review Online

On March 13, a group of patients of suffering from various diseases descended upon Capitol Hill, lobbying their lawmakers to fund the therapies that had successfully treated them — therapies involving the use of adult stem- cells.

One of them, a Long Island woman receiving adult-stem-cell therapy for multiple myeloma, approached Sen. Charles Schumer (D., N.Y.) and told him about the successful treatment she was receiving. According to two other witnesses to the conversation, Schumer told her he supports funding adult-stem-cell research, but added that he did not “share your religious views” and that he also embraces embryonic-stem-cell research.

“But Senator,” the woman replied. “Adult stem cells produce cures. Embryonic stem cells have never produced any cures.”

“Yes they have,” Schumer replied. “I’ve met with two patients that have been treated with embryonic stem cells.”

Schumer’s staff has not yet responded to inquiries on the clearly mistaken answer he gave. In fact, embryonic stem cells have never successfully treated any disease in humans, and human trials of such therapies are more than a decade away, because currently they tend to produce malignant tumors in animal test subjects.

Many writers have already questioned just how promising embryonic research is, given that the best science now suggests that it will never cure Alzheimer’s and it probably won’t cure autoimmune diseases such as juvenile diabetes. But the falsehoods that seem inevitably to accompany embryonic research as a political issue should themselves give voters pause. Why must the backers of this research invoke bad science and sow public confusion every time the issue appears in the public square? Schumer’s statement, even if it is just the result of innocent confusion or scientific ignorance, just is one falsehood among many.


Iowa Basics

I do not use the word “falsehood” here to refer merely to differing philosophical views — even over such important questions as whether an embryo should be treated as a human being. Rather, proponents of embryonic-stem-cell research routinely make misleading and demonstrably false factual claims — about biology, for example, and about prospective embryonic-stem-cell treatments and the therapeutic human-cloning procedures they would require.

The lies go well beyond such fatuous statements as that of former Sen. John Edwards, during the 2004 presidential campaign, that increased federal research funding would make Christopher Reeve “get up out of that wheelchair and walk again.”

The widespread use of even more specific falsehoods helped bring about the repeal of Iowa’s cloning ban last month. The 2002 ban had attached criminal penalties to the creation of human embryos through somatic-cell nuclear transfer (SCNT). Although backers of this procedure go out of their way to avoid calling it what it is, SCNT is the term used in every reputable science textbook to refer to a method of cloning — it is the same method that produced Dolly the sheep.

But as they did in Missouri in 2006 and in California in 2004, supporters of research cloning in Iowa denied that the cloning they planned to do was, in fact, cloning. They even told voters that they were banning cloning. In all three states, thanks to their efforts, the laws now allow cloning by SCNT, but require that clones be killed early on for their stem-cells and not be brought to term. The reason cloning is inseparable from embryonic-stem-cell research is that someday, if therapies are ever developed, patients will need to be cloned (and the clones destroyed at an early stage) in order to obtain the embryonic cells that will cure them.

Those who are claiming to embrace “science” over “politics” in this debate seem to understand this science only in political terms. And they are often less than scientific in the justifications they offer to their constituents.

Former Democratic governor Tom Vilsack, who had signed Iowa’s bipartisan cloning ban in the first place, began the campaign for its repeal with an enormous whopper in his 2006 State of the State address. At the time he signed the ban, he explained…


<<< …we never dreamt that new treatments dependent upon such [nuclear cell] transplants [sic] would be developed so quickly. Well, they have been, and as a result we should revisit our ban on nuclear cell transplants. We should remove the restrictions and allow life-saving treatments to be administered to Iowans here in Iowa rather than forcing them to leave our state. >>>


If there was any exodus of Iowans — perhaps to Illinois — in search of these “life-saving treatments,” it led only to disappointment. The treatments do not exist. It is hard even to guess where Vilsack got the idea to say such a thing, except that he was about to enter the 2008 presidential race and couldn’t find himself on the wrong side of the issue during the Democratic primaries.

The Democratic takeover of Iowa’s state legislature in the 2006 election opened the way to the cloning ban’s eventual repeal, which even then came only by the narrowest of margins. As the debate in Iowa proceeded, several legislators who supported the legalization of cloning for research purposes sent letters to their constituents that blatantly misconstrued or obfuscated what it was they were doing.

State House Majority Leader Kevin McCarthy (D.) wrote a constituent with the following concise explanation:


<<< The bill would allow research that leads to the following; allowing a nucleus from one of these billions of cells (taken from the skin or an eyelash or a fingernail for example) from a specific donor in need of medical treatment———- and then to be transferred to a receptor cell where...in a Petrie dish, cells that exactly match that particular donor are then extracted. >>>

McCarthy wrote that ellipsis in the original in order to skip over the important part, in which the “receptor cell” (a human egg whose nucleus has been removed) receives the new nucleus and begins dividing and developing into a baby because it is then a cloned human embryo. McCarthy went on in the e-mail to assert that scientists have already found from animal experiments that the embryonic cells “can be used to create replacement livers or hearts” for sick patients — which is also false.

Proponents of repealing the cloning ban also tried to assert that they were not producing embryos. State Rep. Patrick Murphy (D) wrote to a constituent that


<<< somatic cell nuclear transfer, which is what this legislation would permit, authorizes the creation of embryonic stem cell lines, which are not even close to actual embryos. There is no sperm involved in somatic cell nuclear transfer, so there can be no embryo. >>>


No embryo? How can one possibly derive “embryonic stem cell lines” without embryos, let alone without “anything close to actual embryos,” whatever that means?

The idea that “no sperm” translates to “no embryo” is laughable from a scientific perspective — the whole idea of cloning is that one can produce an embryo without fertilization. But Murphy’s confused biology does not just reflect the mistaken notions of one state representative — it has become a common scientific fallacy, turning up in a Joplin, Mo. Globe editorial that denies SCNT is cloning or that it produces embryos, on the grounds that SCNT “does not use fertilized eggs.” More frightening, two actual scientists at the University of Nebraska Medical Center, who should know better, have passed along the same lie in order to prevent their state from banning human cloning.

Even James Thompson, the first scientist to isolate and culture embryonic stem cells, scoffed in a 2005 interview at the idea that there was “no embryo” involved in SCNT. “If you create an embryo by nuclear transfer, and you give it to somebody who didn’t know where it came from, there would be no test you could do on that embryo to say where it came from,” he said. “…[Y]ou’re creating an embryo. If you try to define it away, you’re being disingenuous.”

The strangest tale of all, though, came from state Rep. Brian Quick (D.), whose vote was the deciding one in Iowa’s state House last month.
(The bill to allow cloning actually received 52 votes, one more than it needed, because another member intended to vote “no” but accidentally voted “yes.”) Quick, a Catholic who campaigned for office as a pro-lifer, had even been part of the strategy sessions with Iowa Right to Life Committee lobbyist Kim Lehman. She says that he had offered to help bring other Democrats over to vote against repealing the cloning ban. But on the day of the vote, Lehman said, he reversed himself completely.

“[Quick] came out just minutes before the vote and said to me that he didn’t want to see embryos that were going to be thrown away anyway to not be used for research,” said Lehman.

Quick did not return my phone calls after the vote, either to his office or his home. But a quick reading of the bill he helped pass reveals that it had absolutely nothing to do with so-called “surplus” embryos.

“I told him that this bill creates embryos — it’s not a left-over embryo issue here,” she said. “He either thought I was wrong or misled, or he deliberately chose that as his excuse.”

The moral of the story is that those who claim to be on the side of “science” and “reason” are not necessarily wedded to either one when it comes to the politics of embryonic research. Voters in other states should bear this in mind when this bandwagon comes to their towns.


— David Freddoso is a political reporter for Evans and Novak Inside Report.

article.nationalreview.com